ID

39169

Description

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01435174

Link

https://clinicaltrials.gov/show/NCT01435174

Keywords

  1. 12/7/19 12/7/19 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 7, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility End-stage Renal Disease NCT01435174

Eligibility End-stage Renal Disease NCT01435174

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
18-74 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
within 50% of ideal body weight and greater than 40 kg
Description

Ideal Body Weight Percentage | Body Weight

Data type

boolean

Alias
UMLS CUI [1,1]
C0421272
UMLS CUI [1,2]
C0439165
UMLS CUI [2]
C0005910
chronic kidney disease (ckd) stage 5 receiving maintenance hemodialysis for at least 3 months
Description

Chronic kidney disease stage | Maintenance hemodialysis

Data type

boolean

Alias
UMLS CUI [1]
C2074731
UMLS CUI [2]
C4040576
native kidney estimated glomerular filtration rate(gfr) < 10 ml/min
Description

Kidney Native | Estimated Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1,1]
C0022646
UMLS CUI [1,2]
C0302891
UMLS CUI [2]
C3811844
no concurrent illness or evidence of infection
Description

Comorbidity Absent | Communicable Disease Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0332197
able to give informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
qtc interval > 470 msec at echocardiogram (ecg) obtained within the last 6 months
Description

Prolonged QTc interval Echocardiography

Data type

boolean

Alias
UMLS CUI [1,1]
C1560305
UMLS CUI [1,2]
C0013516
concomitant qt-prolonging drugs, major p-gp inhibitors, and cyp3a4 inducers and inhibitors including: cyclosporine, rifampin, rifabutin, rifapentine, phenobarbital, phenytoin, carbamazepine, st. john's wort, ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, ritonavir, indinavir, saquinavir, quinidine, dofetilide, sotalol, amiodarone, erythromycin, thioridazine, ziprasidone, haloperidol, trimethoprim/sulfamethoxazole, ciprofloxacin, norfloxacin, levofloxacin, moxifloxacin
Description

Pharmaceutical Preparations Causing Prolonged QT interval | P-Glycoprotein Inhibitors Major | CYP3A4 Inducers | CYP3A4 Inhibitors | Cyclosporine | Rifampin | Rifabutin | rifapentine | Phenobarbital | Phenytoin | Carbamazepine | ST. JOHN'S WORT EXTRACT | Ketoconazole | Itraconazole | Clarithromycin | nefazodone | Nelfinavir | Ritonavir | Indinavir | Saquinavir | Quinidine | dofetilide | Sotalol | Amiodarone | Erythromycin | Thioridazine | ziprasidone | Haloperidol | Trimethoprim | Sulfamethoxazole | Ciprofloxacin | Norfloxacin | Levofloxacin | moxifloxacin

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0151878
UMLS CUI [2,1]
C3500483
UMLS CUI [2,2]
C0205164
UMLS CUI [3]
C3850041
UMLS CUI [4]
C3850053
UMLS CUI [5]
C0010592
UMLS CUI [6]
C0035608
UMLS CUI [7]
C0140575
UMLS CUI [8]
C0073372
UMLS CUI [9]
C0031412
UMLS CUI [10]
C0031507
UMLS CUI [11]
C0006949
UMLS CUI [12]
C0813171
UMLS CUI [13]
C0022625
UMLS CUI [14]
C0064113
UMLS CUI [15]
C0055856
UMLS CUI [16]
C0068485
UMLS CUI [17]
C0525005
UMLS CUI [18]
C0292818
UMLS CUI [19]
C0376637
UMLS CUI [20]
C0286738
UMLS CUI [21]
C0034414
UMLS CUI [22]
C0114771
UMLS CUI [23]
C0037707
UMLS CUI [24]
C0002598
UMLS CUI [25]
C0014806
UMLS CUI [26]
C0039943
UMLS CUI [27]
C0380393
UMLS CUI [28]
C0018546
UMLS CUI [29]
C0041041
UMLS CUI [30]
C0038689
UMLS CUI [31]
C0008809
UMLS CUI [32]
C0028365
UMLS CUI [33]
C0282386
UMLS CUI [34]
C0536495
pre-study hemoglobin < 9.5 g/dl
Description

Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0518015
plasma albumin < 2.5 g/dl
Description

Plasma albumin level

Data type

boolean

Alias
UMLS CUI [1]
C1272106
liver disease - exclude subjects with a child pugh score of c or higher
Description

Liver disease Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C2347612
positive pregnancy test
Description

Pregnancy test positive

Data type

boolean

Alias
UMLS CUI [1]
C0240802
breastfeeding
Description

Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0006147
allergy to ranolazine
Description

Hypersensitivity Ranolazine

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0073633
participating in another investigational study
Description

Study Subject Participation Status | Clinical Research

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008972
hepatitis b infection due to dialysis isolation requirements
Description

Hepatitis B | Etiology Dialysis Isolation procedure

Data type

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0011946
UMLS CUI [2,3]
C0204727
unstable blood pressure control
Description

Control of blood pressure Unstable

Data type

boolean

Alias
UMLS CUI [1,1]
C1753303
UMLS CUI [1,2]
C0443343
need for routine large fluid removal during dialysis (> 4l)
Description

Removal Fluid Large | Dialysis

Data type

boolean

Alias
UMLS CUI [1,1]
C1883720
UMLS CUI [1,2]
C0005889
UMLS CUI [1,3]
C0549177
UMLS CUI [2]
C0011946

Similar models

Eligibility End-stage Renal Disease NCT01435174

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18-74 years of age
boolean
C0001779 (UMLS CUI [1])
Ideal Body Weight Percentage | Body Weight
Item
within 50% of ideal body weight and greater than 40 kg
boolean
C0421272 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0005910 (UMLS CUI [2])
Chronic kidney disease stage | Maintenance hemodialysis
Item
chronic kidney disease (ckd) stage 5 receiving maintenance hemodialysis for at least 3 months
boolean
C2074731 (UMLS CUI [1])
C4040576 (UMLS CUI [2])
Kidney Native | Estimated Glomerular Filtration Rate
Item
native kidney estimated glomerular filtration rate(gfr) < 10 ml/min
boolean
C0022646 (UMLS CUI [1,1])
C0302891 (UMLS CUI [1,2])
C3811844 (UMLS CUI [2])
Comorbidity Absent | Communicable Disease Absent
Item
no concurrent illness or evidence of infection
boolean
C0009488 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Informed Consent
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prolonged QTc interval Echocardiography
Item
qtc interval > 470 msec at echocardiogram (ecg) obtained within the last 6 months
boolean
C1560305 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
Pharmaceutical Preparations Causing Prolonged QT interval | P-Glycoprotein Inhibitors Major | CYP3A4 Inducers | CYP3A4 Inhibitors | Cyclosporine | Rifampin | Rifabutin | rifapentine | Phenobarbital | Phenytoin | Carbamazepine | ST. JOHN'S WORT EXTRACT | Ketoconazole | Itraconazole | Clarithromycin | nefazodone | Nelfinavir | Ritonavir | Indinavir | Saquinavir | Quinidine | dofetilide | Sotalol | Amiodarone | Erythromycin | Thioridazine | ziprasidone | Haloperidol | Trimethoprim | Sulfamethoxazole | Ciprofloxacin | Norfloxacin | Levofloxacin | moxifloxacin
Item
concomitant qt-prolonging drugs, major p-gp inhibitors, and cyp3a4 inducers and inhibitors including: cyclosporine, rifampin, rifabutin, rifapentine, phenobarbital, phenytoin, carbamazepine, st. john's wort, ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, ritonavir, indinavir, saquinavir, quinidine, dofetilide, sotalol, amiodarone, erythromycin, thioridazine, ziprasidone, haloperidol, trimethoprim/sulfamethoxazole, ciprofloxacin, norfloxacin, levofloxacin, moxifloxacin
boolean
C0013227 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0151878 (UMLS CUI [1,3])
C3500483 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C3850041 (UMLS CUI [3])
C3850053 (UMLS CUI [4])
C0010592 (UMLS CUI [5])
C0035608 (UMLS CUI [6])
C0140575 (UMLS CUI [7])
C0073372 (UMLS CUI [8])
C0031412 (UMLS CUI [9])
C0031507 (UMLS CUI [10])
C0006949 (UMLS CUI [11])
C0813171 (UMLS CUI [12])
C0022625 (UMLS CUI [13])
C0064113 (UMLS CUI [14])
C0055856 (UMLS CUI [15])
C0068485 (UMLS CUI [16])
C0525005 (UMLS CUI [17])
C0292818 (UMLS CUI [18])
C0376637 (UMLS CUI [19])
C0286738 (UMLS CUI [20])
C0034414 (UMLS CUI [21])
C0114771 (UMLS CUI [22])
C0037707 (UMLS CUI [23])
C0002598 (UMLS CUI [24])
C0014806 (UMLS CUI [25])
C0039943 (UMLS CUI [26])
C0380393 (UMLS CUI [27])
C0018546 (UMLS CUI [28])
C0041041 (UMLS CUI [29])
C0038689 (UMLS CUI [30])
C0008809 (UMLS CUI [31])
C0028365 (UMLS CUI [32])
C0282386 (UMLS CUI [33])
C0536495 (UMLS CUI [34])
Hemoglobin measurement
Item
pre-study hemoglobin < 9.5 g/dl
boolean
C0518015 (UMLS CUI [1])
Plasma albumin level
Item
plasma albumin < 2.5 g/dl
boolean
C1272106 (UMLS CUI [1])
Liver disease Child-Pugh Classification
Item
liver disease - exclude subjects with a child pugh score of c or higher
boolean
C0023895 (UMLS CUI [1,1])
C2347612 (UMLS CUI [1,2])
Pregnancy test positive
Item
positive pregnancy test
boolean
C0240802 (UMLS CUI [1])
Breast Feeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])
Hypersensitivity Ranolazine
Item
allergy to ranolazine
boolean
C0020517 (UMLS CUI [1,1])
C0073633 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Research
Item
participating in another investigational study
boolean
C2348568 (UMLS CUI [1])
C0008972 (UMLS CUI [2])
Hepatitis B | Etiology Dialysis Isolation procedure
Item
hepatitis b infection due to dialysis isolation requirements
boolean
C0019163 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0011946 (UMLS CUI [2,2])
C0204727 (UMLS CUI [2,3])
Control of blood pressure Unstable
Item
unstable blood pressure control
boolean
C1753303 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Removal Fluid Large | Dialysis
Item
need for routine large fluid removal during dialysis (> 4l)
boolean
C1883720 (UMLS CUI [1,1])
C0005889 (UMLS CUI [1,2])
C0549177 (UMLS CUI [1,3])
C0011946 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial